Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|05/06/2009||18/08/2009||Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot study of atorvastatin and colesevalam in patients with active ileal Crohn’s disease - Bile salt manipulation in Crohn’s disease||Bile salt manipulation as a novel treatment for Crohn’s disease: a single centre open label pilot study of atorvastatin and colesevalam in patients with active ileal Crohn’s disease - Bile salt manipulation in Crohn’s disease||Active Crohn's disease affecting the ileum |
MedDRA version: 9.1;Level: LLT;Classification code 10011406;Term: Crohn's ileitis
MedDRA version: 9.1;Classification code 10058815;Term: Crohn's disease acute episode
|University College London||NULL||Not Recruiting|| Female: yes|
|13||Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no||United Kingdom|
|06/10/2006||24/02/2005||Atorvastatin in moderat active Crohns disease||Atorvastatin in moderat active Crohns disease||Crohn's disease is an idiopathic chronic inflammatory bowel disease thought to result from inappropriate and ongoing activation of the mucosal immune system driven by the presence of normal luminal flora. It may affect the hole gastrointestinal tract, from mouth to rectum, with symptoms such as diarrhea, weight lose, malabsorption, abdominal pain and fever.||Product Name: atorvastatin||Region Skåne||NULL||Not Recruiting||Female: yes|
|October 2006||29/3/2007||Atorvastatin in Moderate Active Crohns Disease||Crohns Disease||Drug: Atorvastatin||Skane University Hospital||NULL||Completed||18 Years||65 Years||Both||12||Phase 2||Sweden|